FdaApplication
BLA 125265
Identifiers
- fda_app_no: BLA125265
Properties
| Property | Value |
|---|---|
| applicant_name | GlaxoSmithKline Biologicals |
| application_type | BLA |
| approval_date | 2008-04-03 |
Products (3)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| ROTARIX | — | 106.0CCID50 | Suspension |
| ROTARIX | — | 106.0CCID50 | Suspension |
| ROTARIX | — | 1ML | For Suspension |
3 products